newsfilter
← Latest News
GlobeNewswire·

Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada

  • Venus Concept Inc. entered an exclusive distribution agreement with HIRONIC Co. Ltd. to distribute the Doublo 2.0 device in the United States & Canada.
  • The Doublo 2.0 is a multi-energy platform featuring two handpieces for Cold Plasma & RF microneedling treatments.
  • The device holds FDA 510(k) certification & is scheduled for availability in the U.S. during the second half of 2026.
  • Venus Concept will support future regulatory approval efforts in Canada for the device & additional handpiece technologies.
  • CEO Rajiv De Silva highlighted the partnership's focus on synergistic effects from the epidermis to the dermis for comprehensive skin rejuvenation.
  • Venus Concept aims to expand the partnership to include additional HIRONIC technologies once regulatory approvals are secured.
  • Venus Concept operates in over 60 countries with a portfolio including Venus NOVA, Venus Versa, Venus Viva, NeoGraft, & the ARTAS iX system.
  • The company is backed by Madryn Asset Management, a healthcare investment firm supporting growth-stage medical technology companies.